Deciphering GPR35: A Novel Target for Epithelial-Driven Therapeutics in IBD
Time: 1:30 pm
day: Day Two
Details:
- Unravelling the role of GPR35 in epithelial biology to address inflammatory bowel disease progression
- Investigating the therapeutic potential of GPR35 antagonists in preclinical models and patient-derived systems
- Exploring the use of biomarkers to stratify patients for targeted therapeutic interventions and enhanced clinical outcomes
